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A B S T R A C T
Background and aim: Screening for active and latent TB among migrants in low TB incidence countries
may constitute an important contribution to TB elimination. E-DETECT TB, a European multi-county
collaboration, aims to address the present lack of evidence on effectiveness of migrant TB screening by
collating data in an international database and perform cross-country pooled and comparative analyses
of screening coverage, results and linkage to care.
Method: A database was established using migrant TB screening data from participating countries’
national screening programs, national screening pilots and local research projects. All partner countries
contributed to a common agreed protocol with standardized variables, pooling available numerator and
denominator screening data from participating countries and sites.
Results: All collaborating members drafted and agreed upon a data sharing accord as well as a protocol
that clearly deﬁned responsibilities and data governance principles. The database has been created and
data transfer is ongoing.
Conclusion: By persistence and focus the project has overcome considerable administrative, practical and
legal challenges. This international collaboration provides greater power of analysis of harmonized data
and thereby a unique opportunity to contribute migrant TB screening evidence. E-DETECT TB has started
to invite other countries to contribute data to the database.
© 2019 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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In 2017, 258 million people were international migrants due to
conﬂict, inequality, ﬁnancial insecurity and globalisation (Affairs,
2017). This has an impact on Tuberculosis (TB) epidemiology as
some migrants move from high to low TB incidence countries
(Pareek et al., 2016; Odone et al., 2015; Lönnroth et al., 2017). As TB
rates are reaching pre-elimination levels in native populations in
most low TB incidence countries, the proportion of foreign-born* Corresponding author at: Smittskydd Stockholm, Box 17533, 118 91 Stockholm,
Sweden.
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).cases increases (Pareek et al., 2016; Odone et al., 2015; Lönnroth
et al., 2017; Kunst et al., 2017). Screening for active TB and latent TB
infection (LTBI) in migrants in low-incidence countries are
interventions that improve early detection and prevention.
However, more research is needed to address the present evidence
gap concerning coverage, impact and cost-effectiveness of migrant
TB screening (Pareek et al., 2016; Kunst et al., 2017; Getahun et al.,
2015). Screening programs without surveillance of key perfor-
mance indicators could result in a substantial waste of resources
(Zammarchi et al., 2015; Greenaway et al., 2018). Most national TB
registries include data on notiﬁed cases of active TB, but neither
screening data nor information about LTBI diagnosis or treatment
are included (Kunst et al., 2017). International databases that rely
on national reporting therefore have similar limitations, such asiety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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Prevention and Control (ECDC) and the World Health Organiza-
tion’s (WHO) global TB database of nationally aggregated TB
control indicators.
E-DETECT TB is a European research consortium for the early
detection and integrated management of TB in Europe. It is
purposed to contribute to the ultimate elimination of TB in the EU
by means of evidence-based interventions, with a special focus on
generating better evidence for screening (Abubakar et al., 2018).
This paper describes one of the E-DETECT TB work-packages,
which aims to establish a multi-country database for assessing
coverage and results of screening for active and latent TB among
migrants in selected low TB incidence countries in Europe. The
database will in the near future enable evaluations that can guide
proper targeting of screening, appropriate screening approaches
and effective mechanisms that support linkage to care and
adherence.
Methods
General aim and speciﬁc objectives
E-DETECT TB has established a database which contains
migrant TB screening data from national screening programs,
new national screening pilots and local research projects in
selected partner countries. The main aim is to collate data on
migrant TB screening and perform cross-country pooled and
comparative analyses to inform effective screening strategies.
The speciﬁc objectives are to determine: (1) screening coverage;
(2) screening yield/prevalence; and (3) treatment uptake and
completion. These analyses will primarily be disaggregated by
screening scheme/algorithm used, as well as age, sex and
country of origin/nationality of screened individuals. For the
LTBI screening cohort, reactivation rates will be estimated byTable 1
National screening policies or local project approaches at the collaborating sites of the pr
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a From August 2017.
b 2015-July 2017.
c Until 2016: LTBI screening only for non-BCG vaccinated individuals <25 years.
d From December 2016.
e Including Eritrea, due to high-incidence in this group in Sweden.
f Recommended, not programmatic screening.linking to TB registers, where possible. For those screened for
active TB with chest X-ray (CXR), CXR ﬁndings and character-
istics of clinically diagnosed TB will be assessed. The results will
also be used to parameterize health economic and transmission
models.
Study partners
The work is led by members of the E-DETECT TB consortium
with support from national public health agencies (Home, 2018).
The present collaborators are Italy (University of Brescia), the
Netherlands (KNCV Tuberculosis Foundation), Sweden (Karolin-
ska Institutet and the Public Health Agency of Sweden) and the
United Kingdom (University College London and Public Health
England). Additional partners and countries are invited to join the
database.
Study design
A multi-country cohort study of migrants eligible for LTBI/TB
screening according to the given country’s existing national policy
and local screening protocols (Table 1) was conceived (Lönnroth
et al., 2017). Based on careful mapping of available data on LTBI/TB
screening, all partners have developed and agreed on a common
protocol for data sharing, analysis and dissemination(Kunst et al.,
2017). This includes a variable list with standardized variable
names and codes to be used across sites. Each country created a
standardized database that captures the cascade of screening and
linkage to care from which a dataset will be extracted and merged
with the joint multi-country database containing a cohort of
individual level data. The joint database includes one module for
basic demographic information, as well as ﬁve modules represent-
ing the screening and linkage-to-care cascade and reactivation
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Figure 1. The screening and linkage-to-care cascade.
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All those included in systematic screening and logged in the
national or project databases are eligible for inclusion in the
cohort. Data on screening for active TB is available from the UK
(pre-migration, for visa applicants) and the Netherlands (post
arrival, for selected migrants) on a national level. LTBI screening
data is available from England and from selected sites in Italy, the
Netherlands and Sweden.
Duration of study
The database was created in 2018. Retrospective data has been
transferred from each site from the ﬁrst year available and at least up
to December 2017. Further prospective data will be added yearly. The
initial analyses will be performed employing data from 2005 to 2018.
In 2019, additional countries will be invited to contribute data. Our
vision is that the database will continue to be used in perpetuity.
Data collection
Each partner collects, cleans and recodes the individual level data
accordingtotheagreedvariablelist,beforetransfertothejointdatabase.
Variation in screening policies, data collection and recruitment make
the data somewhat heterogeneous and not all partners contribute to all
datamodules. Thevariablesessential totheobjectivesof theproject are:country of screening, screening scheme, sex, age, country of origin,
screening performed and screening results. Where available, data on
initiated and completed treatment will be included.
For active TB, the Netherlands collect data from national data
registry on new immigrants reporting for TB screening at the
Public Health Services, whereas the United Kingdom collect data
from overseas clinics for pre-entry screening.
For latent TB, Italy and the Netherlands have projects wherein
they collect data.
Sweden collects data on migrants invited to a health examina-
tion (which includes TB screening) both for attending and declined
individuals. The data is collected by use of the invitation and
monitoring tool called “Hälsoplan”, which is based on data from a
registry kept by the Swedish Migration Authority and data in
electronic medical records in Stockholm Region’s Health Services.
TB screening results and cascade of care data is extracted centrally
from electronic medical records. So far, only data from Stockholm
County is included, but additional regions will be invited.
The United Kingdom has an LTBI testing and treatment data
collection system wherein data is collated from GP-systems,
laboratory systems and secondary care.
Data management and analysis
The pooled data is stored in the Data Safe Haven (DHS) at the
Institute of Health Informatics at University College London (UCL)
Figure 2. Data modules for the different steps in the screening and linkage-to-care cascade.
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information security standard and is built using a walled garden
approach, where the data is stored, processed and managed within
the security of the system. It includes a simple and secure ﬁle
transfer mechanism (Informatics, 2018). Pseudonymized data (no
personal identiﬁers) is uploaded to the DSH by the data controller/
manager for each study partner. To access the DHS an Information
Governance training and certiﬁcation from DSH is needed. Data are
transferred, and stored following the principles of the EC Directive
on personal data protection and conﬁdentiality, the General Data
Protection Regulation (GDPR) (EC/2016/679) (Union, 2018).
The joint database does not include personal identiﬁers, instead
each individual has a serial number. Each partner keeps personal
identiﬁers in the original country or partner database (in
accordance with GDPR and local ethics clearance), with a key
linking serial number to the personal identiﬁer. This level of
anonymity could enable future linkage by a trusted third-party
collaborator. Data regarding reactivation will be collated and a
research structure for TB reactivation is under development in each
country.
The E-DETECT TB steering group is the overall data controller
and will decide on all data analysis and presentation, as well as on
allowing contribution and access to data for future partners.
Ethical and legal considerations
Measures have been taken to eliminate the risk of identiﬁcation
of individual subjects in the pseudonymized multi-country
database, including collapsing country of origin categories when
there are only few screened individuals from one speciﬁc country.
Each partner is responsible for legal and ethical considerations for
data extraction, sharing and analysis. The sharing of data followsthe regulations of each respective participating country, and the
principles of GDPR (Union, 2018). Data sharing agreements have
been established between project partners and UCL, deﬁning data
management, access, and safety in line with each institution’s and
country’s regulation.
The UCL partner was approved per the notiﬁcation of Ethics
Approval with Provisos Project ID/Title: 12371/001: Early detection
and integrated management of tuberculosis in Europe – EDETECT
TB database for Work Package 6. Stockholm Region was granted
two ethical approvals and one amendment for this project from the
Regional Ethical Review Board in Stockholm (2016/1974-31/5,
2018/1901-32 and 2016/1648-32). Ethics approval for Italian data
collection was received from the competent Ethics Committee
(Comitato Etico Provinciale di Brescia) (NP 2808 and NP 2901).
Discussion
The present lack of systematically collected and reported,
consolidated data on the process and outcomes of systematic
screening for active and latent TB hampers the development of
policies and guidelines (Pareek et al., 2016; Odone et al., 2015). All
EU countries have a national TB registry that includes notiﬁed
information on individuals detected with active TB. However, LTBI
is generally not notiﬁable, and few countries collect data on the
number of persons diagnosed with LTBI, or persons receiving
preventive treatment. Absolute numbers for active TB are most
often available and absolute numbers of LTBI cases are sometimes
available, but denominator data on number of people screened are
rarely available, for both active and latent TB (D'Ambrosio et al.,
2014; Erkens et al., 2016). Therefore, from existing national and
international surveillance systems the number needed to screen to
detect one case and contribution to case detection from screening
J.N. Öhd et al. / International Journal of Infectious Diseases 80 (2019) S45–S49 S49are mostly unknown. This international collaboration, which is
standardizing and pooling available numerator and denominator
screening data from several countries provides greater power of
analysis of harmonized data.
Data on screening results alone are not enough to assess the
public health impact of screening. It is also important to gather data
on the completeness of the care cascade from screened to completed
treatment and, in case of LTBI, determine rate of reactivation for non-
treated and treated individuals (Pareek et al., 2016; D'Ambrosio et al.,
2014; Erkens et al., 2016). The present project represents a unique
opportunity to obtain such data across several countries.
The establishment of a joint international database necessitates
for several technical, administrative and legal challenges to be
addressed. A main technical challenge was the lack of a
standardized national recording and reporting routines for TB
screening. Furthermore, differences between countries with
regard to data sources, data variables collected, and deﬁnitions
used added complexity. In some sites, collecting data from existing
data sources in diverse data formats entailed practical and time-
consuming challenges. Indeed, by identifying challenges for data
extraction and collation, the E-DETECT TB project has already
helped improve data availability and quality for some partners. The
process of analysing existing data sources and developing the
protocol has stimulated discussions on how data recording and
reporting can be improved and standardized. For example, the E-
DETECT TB project has helped facilitate improvements in the data
recording and reporting in Stockholm, where structured data
recording for LTBI/TB screening of asylum seekers now includes;
the screening done, screening results, country of origin, age and sex
as directly extractible variables. Moreover, in the Italian sites the
monitoring and evaluation systems for the migrant TB screening
has become more standardized and are now fully harmonized with
the E-DETECT TB protocol.
Administrative, practical and legal challenges have not been
trivial. Collecting and analysing sensitive data of vulnerable groups
such as migrants need thorough ethical consideration with
sensitivities applied to the responsible presentation of the results.
Establishing the necessary permissions, to be allowed to extract data
from medical records is a time-consuming process that often
includes numerous meetings with involved parties to facilitate a
common understanding of the signiﬁcance of the project. A rigorous
data governance and management system has now been set up and
agreed as a result of this process. Data ownership and uncertainties
on how to share data within and across countries have been
thoroughly investigated within the project. A data sharing agree-
ment and protocol that clearly deﬁned responsibility and safeguard-
ing of data was drafted and agreed upon by all members. An
agreement that will also be useful for eventual future collaborators.
The database has now been created, data transfer is ongoing,
and E-DETECT TB has started to invite other countries to contributedata to the database. The database will be a useful source of
knowledge for EU-members states as well as other countries with a
low incidence of TB and a large part of TB cases among the foreign-
born population.
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